[{"StockholdersEquityConverted_0_FY_USD":106256000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-399714000.0,"CommonStockSharesOutstanding_0_FY_shares":122849389.0,"StockholdersEquity_0_FY_USD":57906000.0,"EarningsPerShareBasic_4_FY_USD":-3.8,"RevenuesConverted_4_FY_USD":8249000.0,"Assets_0_FY_USD":703588000.0,"CommonStockSharesConverted_0_FY_shares":125264070.0,"NetIncomeLossConverted_4_FY_USD":-448724000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210225"}]